Study aims to uncover why a deadly lung disease is often diagnosed too late
NCT ID NCT06998329
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how long it takes for people in Brazil to get a correct diagnosis of pulmonary arterial hypertension (PAH), a rare and serious lung disease. Researchers will review medical records of about 139 adults diagnosed in the last five years to find out what causes delays. The goal is to help doctors diagnose PAH earlier, which could lead to better treatment and outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
InCor - Universidade de São Paulo
RECRUITINGSão Paulo, São Paulo, 05048000, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaled therapy replace a daily pill for PAH?
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Could a gut bacteria transplant ease a rare lung disease?
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?
- Can a Real-World registry improve how treprostinil is used for PAH?
- Can a smartwatch replace the clinic walk test for lung disease patients?